Prescribing indicative

S. No. Name of Substance Quantity Prescribed Indicator Employed Calculations... 

This is a mechanism by which an independent prescriber indicates that a patient should be given a particular medicine (indicating amount, route of administration, etc). It can be achieved by writing an instruction within the patient case notes or, for example by a doctor indicating on an X-ray request form that particular medication should be given as part of the examination. 

The most effective specification is that which accomplishes the desired result with the fewest requirements. Properties and performance should be emphasized rather than how the objectives ate to be achieved. Excessive demonstration of emdition on the part of the writer or failure to recognize the usually considerable processing expertise held by the vendor results in a lengthy and overly detailed document that generally is counterproductive. Redundancy may lead to technical inconsistency. A requirement that cannot be assessed by a prescribed test method or quantitative inspection technique never should be included in the specifications. Wherever possible, tests should be easy to perform and highly correctable with service performance. Tests that indicate service life are especially useful. Standard test references, eg, ASTM methods, ate the most desirable, and those that ate needed should be selected carefully and the numbers of such references should be minimized. To eliminate unnecessary review activity by the would-be complier, the description of a standard test should not be paraphrased or condensed unless the original test is referenced. 

A final area of research focuses on how the piU. can best be used by women. Physicians used to recommend pid-free hoHdays, but it is now known that there is no vaUd reason for this practice. Similarly, further research indicated that the U.S. EDA s restrictive guidelines for prescribing the piU. to women over the age of 35 are not justified, and those guidelines have been changed. EinaHy it is clear that cigarette smoking increases the risk of cardiovascular side effects, especially in women over 35 who utilize combination oral contraceptives. 

Table A13.. s also indicates the test results of the samples of the final discharge when the effluents are treated along similar lines as discussed later. The test results are well within the tolerable limits. The recommended tolerance levels are provided in Table A 13.6, Any constituent exceeding the prescribed limits must be properly treated before final discharge.

Infusion Boiling water (150 250 ml) is poured over the prescribed amount of drug in a heat-resistant glass or porcelain vessel, which is then covered if necessary, the contents are stirred occasionally. If no other indication is given, the contents arc strained after 5 -10 min. This method can be used for most leaves, flowers, and herbs and also for many correspondingly comminuted barks and roots. 

A completed Form R must be submitted for each toxic chemical manufactured, processed, or otherwise used at each covered facility as prescribed in the reporting rule in 40 CFR Part 372 (published February 16,1988 in the Federal Register). These instructions supplement and elaborate on the requirements In the reporting rule. Together with the reporting rule, they constitute the reporting requirements. All references in these instructions are to sections in the reporting rule unless otherwise indicated. 

A signed statement by management without its approval to the quality system documented policies and procedures will indicate that it is not committed to honoring the policies and procedures. Managers need to approve the documents within the quality system that prescribe activities for which they themselves are responsible. This serves to demonstrate that they agree with the manner in which the policy has been interpreted and are prepared to provide the resources needed to implement the documented practices. 

You are only required to indicate whether product conforms to the inspections and tests performed. This is not the same as indicating whether the product conforms to the customer requirements. It may well pass the prescribed inspections and tests but these inspections and tests may not be sufficiently comprehensive to verify conformance to all the customer s requirements. However, the only indication you can give is the product s conformance or nonconformance with some verification requirement. It follows therefore that you should not go around putting reject labels on products, or acceptance labels for that matter, if you have not performed a specific inspection to determine conformance. There are only three conditions uninspected , inspected and found conforming , and inspected and found nonconforming . If you have a policy of only applying labels after inspection, anything without a label is therefore deemed uninspected, unless it has been installed and the label removed. 

This contains two separate requirements one for verifying that the prescribed action has been taken and the other for verifying that the action has been effective in eliminating the original nonconformity. The Corrective Action report should define the corrective action to be taken, the actionee, and the date by which it is to be completed. The action-ee should report when the action has been completed in order that it may be verified. The effectiveness of some actions can be verified at the same time but quite often the effectiveness can only be checked after a considerable lapse of time. Remember it took an analysis to detect the nonconformity therefore it may take further analysis to detect that the nonconformity has been eliminated. In such cases the report should indicate when the checks for effectiveness are to be carried out and provision made for indicating that the corrective action has or has not been effective. 

---